Of 22 randomized trials of rehabilitation with exercise after myocardial infarction (MI), one trial had results that achieved conventional statistical significance. To (OR= 1.09 [0.88, 1.341) of follow-up. The observed 20% reduction in overall mortality reflects a decreased risk of cardiovascular mortality and fatal reinfarction throughout at least 3 years and a reduction in sudden death during the 1st year after infarction and possibly for 2-3 years. With respect to the independent effects of the physical exercise component of cardiac rehabilitation, the relatively small number of "exercise only" trials, combined with the possibility that they may have had a formal or informal nonexercise component precludes the possibility of reaching any definitive conclusion. To do so would require a randomized trial of sufficient size to distinguish between no effect and the most plausible effect based on the results of this overview. (Circulation 1989;80:234-244) T he potential value of rehabilitation with exercise in individuals with coronary heart disease was recognized nearly as early as the clinical description of the disease itself. In 1772, Heberdent noted that one of his patients with CHD was "nearly cured" after 6 months of sawing wood for half an hour a day. In the United States, each year over one million individuals experience myocardial infarction and 670,000 survive.2 Ambulation See p 416 early after myocardial infarction, the use of exercisebased cardiac rehabilitation, and the modification of cardiovascular risk factors are widely practiced.
T he potential value of rehabilitation with exercise in individuals with coronary heart disease was recognized nearly as early as the clinical description of the disease itself. In 1772, Heberdent noted that one of his patients with CHD was "nearly cured" after 6 months of sawing wood for half an hour a day. In the United States, each year over one million individuals experience myocardial infarction and 670,000 survive.2 Ambulation See p 416 early after myocardial infarction, the use of exercisebased cardiac rehabilitation, and the modification of cardiovascular risk factors are widely practiced.
Cardiac rehabilitation programs are of two general types: exercise training plus other risk factor interventions and exercise training alone. Exercise in individuals with coronary heart disease increases the efficiency of oxygen extraction and metabolism in skeletal muscle, thereby reducing cardiac work, and also improves coronary artery collateral blood flow.3-6 In addition, observational epidemiologic studies have indicated that regular exercise may decrease cardiovascular death rates in those with preexisting disease.7 Although over 4,700 patients have been randomized in trials of cardiac rehabilitation, the individual studies have been far too small to distinguish reliably between any moderate (e.g., 15 -30%), yet worthwhile, reduction in morbidity and mortality that might plausibly be expected and an absence of any medically significant benefit.8-25 Consequently, the value of rehabilitation programs has not yet been shown convincingly. In this circumstance, a more reliable estimate of any true net benefit of cardiac rehabilitation programs with exercise may be obtained by an overview. Several prior cumulative analyses have assessed some of the effects of rehabilitation after myocardial infarction, yet in contrast to the present review, none has included all clinically important endpoints or analyzed treatment effects by time after infarction. [26] [27] [28] [29] In this overview of randomized trials of postmyocardial infarction rehabilitation that included a structured exercise component, the results of each trial are presented separately with an "overview" of all of them, which was constructed in a way that avoids any unjustified assumptions about the comparability of different studies. Results are presented by intervention type, "exercise only" and "exercise plus other interventions," and by a combination of both types. Such an overview of all directly relevant randomized trials serves two purposes.30,3' First, it minimizes the effect of chance in assessing the effects of treatment on fatal and nonfatal endpoints.
Second, it avoids the biases that may be introduced by outcome-dependent emphasis on particular studies or on particular "subgroups" of subjects.
Methods
We reviewed all published randomized trials of rehabilitation after myocardial infarction with objective and reproducible entry criteria, and we performed an overview to compute an estimate of the pooled or typical odds ratio and its 95% confidence interval for the trials combined.
Acquisition of Data
The literature (including abstracts from meetings) was scanned by a formal, computer-aided search and by an informal search for studies that were known to our research group. Data on total and cardiovascular mortality and nonfatal reinfarction were obtained for each completed randomized trial of postmyocardial infarction rehabilitation that included a structured exercise component (Table 1) . In many instances, the principal investigators of the individual studies were contacted for additional details regarding the intervention, excluded patients, mortality data in subgroups or time periods, and other information when such data could not be found in the published reports. Studies that used methodologies other than randomization (such as alternate allocation, year of birth, or retrospective controls) were not included (Table 2) .
Definition of Endpoints
The endpoints used in this study were total mortality, cardiovascular mortality, sudden death, and fatal and nonfatal myocardial infarction. It is not possible to strictly apply uniform criteria to the endpoints without access to actual patient records, so the definitions used by the investigators of the original studies were retained. This variability of definition probably did not influence the ascertainment of total cardiovascular mortality; however, it may have affected the analysis of sudden death and nonfatal infarction. However, because trials are randomized and the comparisons are made within the individual studies, the problem of definition of endpoints probably did not introduce any material bias into the overall results. The endpoints were also assessed with respect to the time from randomization, where possible, and assessments of the effect of rehabilitation were made at 1, 2, and 3 or more years after randomization.
Statistical Analysis
We used the standard methods for the combination of information from 2x2 tables (e.g., rehabilitation/comparison vs. diseased/not diseased) described in the Appendix of the report by Yusuf et al.32 In this analysis, subjects were not excluded because of nonadherence to trial protocols; it is an "intention to treat" analysis. The Examination of the statistic GT implicitly assumes that data from all randomized trials are available without any material bias due to nonavailability of unpromising results or to patient withdrawals. It does not implicitly assume, however, that patients in one trial can be compared directly with patients in another, for it is based entirely on comparison of patients in particular trials with others in those same trials, nor does it implicitly assume that any real effects of the rehabilitation programs in different trials should be similar. An estimate of the typical ratio of the odds of death among those randomly assigned to the rehabilitation program to that among comparison subjects is given by GT/SIV with approximate 95% confidence intervals exp(GT/SIV+ [1.96/ 
Results

Characteristics of the Trials
A careful search of the literature identified reports of 36 randomized trials of cardiac rehabilitation that included a structured exercise component. These trials were conducted between 1960 and 1988. Twenty-four of these trials were coordinated by the World Health Organization (WHO) study of cardiac rehabilitation. Although the same general protocol was used by each of the WHO sites, the method of randomization varied between sites; therefore, in this analysis, they are considered as separate studies. These trials varied greatly in the number of patients randomized, from 54 in a study conducted at Duke University to over 700 in the Ontario Exercise Heart Study. The length of follow-up varied from less than 1 year to 5 years; however, approximately two thirds of the studies had a 3-year follow-up period.
Selection of Trials for Analysis
Each of the trials was assessed to determine whether or not it was suitable for inclusion in this analysis. Twenty-two trials were included in the analysis (Table 1 ) and 14 were excluded (Table 2) . Seven WHO sites failed to contribute data to the published report. Three WHO sites did not randomize patients individually. The San Diego trial was excluded because not all subjects were studied after MI. The trials conducted by investigators at Stanford University and Duke University were excluded because the follow-up period was less than 1 year.
Of these 22 trials in the analysis, only four included women. Of 315 randomized subjects at Goteborg, 35 (11.1%) were women, whereas at Torino, Italy, of 167 randomized subjects, 37 (22.2%) were women. At Helsinki and Turku, sites of the WHO cooperative trial, 74 of 375 subjects (19.7%) were women; however, because detailed outcome information was available for men only, the analysis presented includes men only. Thus, women constitute approximately 3% of the randomized subjects. It was impossible to exclude this small number of women from the analysis or to draw any firm conclusions about them.
With regard to age, the trials generally excluded individuals older than 65-70 years of age. In the Goteborg trial, all subjects were less than 55 years of age; for the Amsterdam trial, the age range was 40-55 years. Thus, the analysis is heavily weighted toward men in the 5th and 6th decades of life.
The length of time from myocardial infarction to randomization varied from 5 days after hospital admission (Alton-Hants, UK) to over 3 years (National Exercise Heart Disease Study); most trials used the range of 1-3 months. The National Exercise Heart Disease Study and the Ontario Exercise Heart Study were the only trials in which the time from myocardial infarction to randomization for some participants was substantially greater than 6 months.
For inclusion in this analysis, a structured physical exercise program had to be included in the intervention. In general, the subjects were randomized either to a structured program of physical exercise or to usual activities of daily living. In the Ontario Exercise Heart Collaborative Study, subjects were randomized to either high intensity and high frequency (4 sessions/wk) or low intensity and low frequency (1 session/wk) physical exercise. The structured exercise programs generally lasted from 2-6 months, and subjects were then encouraged to continue an unsupervised exercise program. Practically all trials included a formal or informal nonexercise component. This ranged from advice given to subjects by project staff to an organized, multidisciplinary intervention involving social workers, psychologists, dietitians, and others. Many of these interventions stressed smoking cessation and dietary changes. In addition, because lifestyle modifications are well known to both medical professionals and the general public, the comparison group was almost certainly advised to modify these risk factors. In the analysis, trials were classified as "exercise only" or "exercise plus other interventions." Overview Results
A total of 4,554 patients were randomized to rehabilitation (n=2,310) or comparison (n=2,244) groups. Of 502 deaths, 412 (82.1%) were identified as cardiovascular-related and 202 as sudden deaths. There were 701 reinfarctions of which 312 (44.5%) were fatal.
For each individual trial, the observed and expected values for total mortality were calculated. In 17 of 21 studies, the difference between observed and expected numbers of deaths (0-E) was 0 or less, indicating a protective effect against total mortality. In the overview, the odds ratios and 95% confidence intervals for 1, 2, and 3 years were 0.77 (0.59, 1.01), 0.74 (0.59, 0.92), and 0.80 (0.66, 0.96), respectively (Table 3) . Although some of the individual trials produce odds ratios greater than 1.0, there is no statistical evidence of heterogeneity. Figure 1 shows the odds ratios and 95% confidence limits for total mortality 3 years after randomization for each individual trial. A horizontal line depicts the 95% confidence interval, and a short vertical line depicts the point estimate. At the bottom of the figure are the pooled or typical odds ratio and confidence interval. The point estimates of the individual trials are, in general, very consistent with Follow-up less than 1 yr intensity (65-75% Vo2 max) or low-intensity (<45% Vo2 max) exercise. All were given information on low-fat, low-cholesterol diets the odds ratio. The one trial with a point estimate differing widely from the overall has a wide confidence interval. The upper bound of the confidence intervals for all but two of the individual studies includes 1.0; thus, they are not statistically significant. The confidence interval for the typical odds ratio is much narrower. The typical odds ratios for total mortality were quite similar in the "exercise only," 0.81 (0.60, 1.10), and the "exercise plus other interventions" groups, 0.79 (0.62, 1.01).
Because most deaths after myocardial infarction are cardiovascular related, the data on cardiovascular mortality are consistent with those for total mortality ( Table 4 what lower in the "exercise plus other interventions" group than in the "exercise only" group. For fatal myocardial infarction, the odds ratios and 95% confidence intervals for 1, 2, and 3 years were 0.67 (0.48, 0.94), 0.73 (0.54, 0.97), and 0.75 (0.59, 0.95), respectively. Results were similar in the "exercise only" and the "exercise plus other interventions" groups, and there was no statistically significant heterogeneity (X2het=25.08,p=0.09).
The results for nonfatal reinfarction were similar in the intervention and comparison groups. The odds ratios were 1.09 (0.76, 1.57), 1.10 (0.82, 1.47), and 1.09 (0.88, 1.34) . The odds ratios were somewhat higher in the "exercise plus" studies than in the "exercise only" studies, and the x2 test of heterogeneity was not significant (K2het=28.80, p=0.07).
Discussion
This overview of randomized trials of cardiac rehabilitation with exercise indicates a moderate reduction of about 20% in total and cardiovascularrelated mortality. These results are apparent 1 year after randomization, are statistically significant, and persist throughout the follow-up period.
The odds ratios for sudden death show a large reduction (0.63 [0.41, 0.97]) in risk during the 1st year after randomization and suggest a benefit during the 2nd and 3rd years after randomization but are not statistically significant. Although the highest incidence of sudden death is during the 1st year after myocardial infarction, we have only the time after randomization (not the time from myocardial infarction), and we know from the published reports (Table 1 ) that the time from myocardial infarction to randomization varied from the day of hospital admission (Austin Hospital, Victoria, Australia) up to 36 months after hospitalization (National Exercise Heart Disease Study, USA). Thus, for sudden death, these data were somewhat heterogeneous, which may bias the results toward the null.
Nonfatal myocardial infarction occurred somewhat more commonly in the rehabilitation group than in the comparison group, 10.2% vs. 9.5%. This occurrence persisted throughout the follow-up period but was not statistically significant (1.09 [0.88, 1.34]). It may be due to chance or may represent either a true increase in the frequency of nonfatal myocardial infarction or increased survival from myocardial infarction.
In interpreting the results observed in this overview, chance is an unlikely alternative explanation. Typical odds ratio for "exercise only" studies 95% confidence interval Typical odds ratio for "exercise plus" studies 95% confidence interval 0-E, observed minus expected mortality; WHO, World Health Organization; NA, data not available; NAC, data not available for calculations; . ., data not available because of no follow-up. of 21 odds ratios for total mortality are between 0.12 and 1.0. As expected, the "harder" endpoints, that is, total and cardiovascular-related mortality, show more precision than the "softer" endpoints, that is, nonfatal myocardial infarction and sudden death. Tests of heterogeneity were calculated for each endpoint and for each period of follow-up and did not show any statistically significant heterogeneity.
Confounding cannot be absolutely excluded but is an unlikely explanation. Only trials that randomized patients individually were included in the analysis. Specific information on individual patients was not always available; thus, confirmation that the randomization was successful was generally not possible. However, the large number of patients randomized would be likely to yield comparable groups.
Of greater concern would be heterogeneity in the intervention, which 
. . statistically significant heterogeneity, the odds ratios for cardiovascular-related mortality and for sudden death were substantially lower in the "exercise plus other interventions" trials than in the "exercise only" trials. However, the relatively small number of "exercise only" trials contributing to these endpoints does not allow definitive conclusions. Interactions between exercise and other risk factors cannot be addressed in this overview. The conclusions drawn from these results must be interpreted as are the results of any trial, as a test of the entire intervention, that is, exercise-based cardiac rehabilitation after myocardial infarction. Two sources of potential bias must be addressed: the effects of incomplete ascertainment and publication bias. Through the careful review of the published reports and mail and telephone contact with the investigators, we were able to obtain most of the endpoints required for these analyses. For total mortality, cardiovascular mortality and fatal myocardial infarction at 3 years after randomization, 100%, 92.5%, and 86% of the endpoints were ascertained. In several trials, only the number of deaths was reported, and we were unable to ascertain the type of death. Nevertheless, mortality follow-up is complete. For nonfatal myocardial infarction, the percentage of endpoints ascertained at 3 years after randomization was 90.1%. Those endpoints that were missing tended to be the tabulations of nonfatal myocardial infarction for trials that were initially analyzed by a time frame different from that used in this overview. The ascertainment of sudden death was substantially less (68%) than the other endpoints.
SUM
When endpoints are missing, two types of distortions may result. If the missing data are similar to those that were obtained, the missing data produce only a loss of precision for that endpoint, that is, a bias toward the null. If the unavailable data were substantially different, the direction of the distortion could not be predicted from the available data. This could result from a publication bias due to suppression of unpromising results: either the investigator or editors could be reluctant to publish negative trials. It is reasonable to expect rehabilitation to have a beneficial effect on cardiovascular morbidity and mortality. Exercise training improves functional work capacity, thereby decreasing the metabolic and circulatory demands of daily activities. Physical training usually lowers the heart rate and blood pressure, which are two major determinants of myocardial oxygen demand.33 These adaptations are accompanied by significant reductions in circulating levels of norepinephrine.34 In addition, exercise helps to reduce weight, increase lean body mass when caloric content is constant, lower serum triglycerides, increase high-density lipoproteins, decrease platelet adhesiveness, enhance fibrinolysis, and lessen the adrenergic response to stress. 35 In addition, changes in smoking behavior, diet modification, and overall closer medical supervi- after infarction. Sudden death seems to be reduced during the 1st year after infarction in the "exercise plus other interventions" trials. There is no evidence for the reduction of risks of nonfatal reinfarctions. The relatively small number of "exercise only" trials, combined with the possibility that they may have had a formal or informal nonexercise component, does not allow definitive conclusion to be reached about the independent effects of the physical exercise component of cardiac rehabilitation. The future conduct of a randomized trial of sufficient sample size is necessary to provide direct evidence of therapeutic effectiveness. At least 4,000 patients will be required to reliably distinguish between no effect and the most plausible alternative of a 20% reduction in cardiovascular-related mortality as suggested by this overview.
